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Reference Values for 24-Hour Ambulatory Blood Pressure
Monitoring Based on a Prognostic Criterion
The Ohasama Study
Takayoshi Ohkubo, Yutaka Imai, Ichiro Tsuji, Kenichi Nagai, Sadayoshi Ito,
Hiroshi Satoh, Shigeru Hisamichi
Abstract—Although reference values for ambulatory blood pressure (ABP) monitoring have been investigated in several
population studies, these values were derived from cross-sectional observations and were based merely on the statistical
distribution of blood pressure values. Therefore, we conducted a prospective cohort study to identify reference values for
24-hour ABP in relation to prognosis. We obtained measurements of 24-hour ABP for 1542 subjects (565 men) aged 40 years
and over in a general population of a rural Japanese community and then followed-up their survival status. There were 117
deaths during the follow-up period (mean, 6.2 years). The association between baseline 24-hour ABP values and mortality,
examined by the Cox proportional hazards regression model adjusted for possible confounding factors, showed a better fit
with a second-degree equation than with a first-degree equation. On the basis of the results of this analysis, we identified the
following reference values as the optimal blood pressure ranges that predict the best prognosis: 120 to 133 mm Hg for systolic
blood pressure and 65 to 78 mm Hg for diastolic blood pressure. 24-Hour ABP values .134/79 mm Hg and ,119/64 mm Hg
were related to increased risks for cardiovascular and noncardiovascular mortality, respectively. This is the first report to
propose reference values for 24-hour ABP based on a prognostic criterion. (Hypertension. 1998;32:255-259.)
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Noninvasive techniques for measuring ABP now make itpossible to monitor blood pressure during activity and
sleep and provide more reproducible information than casual
(screening) blood pressure measurements.1–4 Target-organ
damage and cardiovascular morbidity are more strongly
correlated with ABP than with casual blood pressure.3–12
However, there is no consensus on the use of ABP to
diagnose and manage hypertension,3,4,13–17 in part because
reference values have not been established. Proposed refer-
ence values for ABPM are based on cross-sectional observa-
tions.18–22 However, because the reference value must be the
value that best predicts the risk of morbidity and mortality, a
longitudinal study in a general population is needed to
investigate the prognostic significance of the value.
We initiated ABPM in the general population of a rural
Japanese community18 and have been monitoring the survival
of these individuals since 1987.23,24 The objective of the
present study is to propose the reference values for 24-hour
ABPM in relation to prognosis and to investigate the prog-
nostic significance of the value.
Methods
Design
The present report is based on a longitudinal observation of subjects
who have been participating in an ABP measurement project in
Ohasama, Iwate Prefecture, Japan, since 1987. The socioeconomic
and demographic characteristics of this region and the details of the
study project have been previously described.18,23,24
The study protocol was approved by the Institutional Review
Board of Tohoku University School of Medicine and by the
Department of Health of the Ohasama Town Government.
Study Population
The selection of study subjects has been previously described.23,24 In
brief, of the 2716 residents of Ohasama aged 40 years or older, 575
were excluded because they worked outside of town. This exclusion
criterion was necessary because public health nurses visited subjects
to attach the ABPM devices during the workday. We also excluded
hospitalized individuals (n5121) and demented or bedridden indi-
viduals (n531). Thus, 1989 individuals were eligible for the study.
Of the eligible residents, 447 declined to participate for various
reasons. Thus, the study population consisted of 1542 individuals,
representing 78% of the total eligible population (565 men, mean age
of 62.5 years; 977 women, mean age of 61.2 years). We previously
confirmed that the study population was representative of the general
population.23,24 Informed consent was obtained from all subjects.
Ambulatory Blood Pressure Monitoring
Well-trained public health nurses visited participants on a weekday
morning to attach the ABPM device and returned to detach it the next
morning. Participants were asked to keep a diary in which they
recorded their daily activities, including the time at which they went
to bed and when they got up.
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Blood Pressure Monitoring Device
ABP was monitored with the ABPM-630 (Nippon Colin), a fully
automatic device25,26 preset to measure blood pressure every 30
minutes. Although SBP and DBP were measured by both the
cuff-oscillometric method and the microphone method, we used only
data obtained by the cuff-oscillometric method for analysis. Because
the circumference of the arm was ,34 cm in most cases, we used a
standard arm cuff for both blood pressure measurements. The ABPM
device used in the present study has been previously validated25,26
and meets the criteria of the Association for the Advancement of
Medical Instrumentation.27
Data Analysis
ABP data were included in the analysis if the monitoring period
included .8 waking hours (daytime) and .4 hours during the time
the subject was in bed (nighttime). These periods were estimated
from the subjects’ diaries. If the 24-hour ABPM data were not
complete, the 24-hour average ABP was calculated as follows:
24-hour average ABP5(daytime average3waking hours1nighttime
average3sleeping hours)/24, where sleeping hours represent the
time the subjects spent in bed (waking hours1sleeping hours524
hours). The mean6SD duration of monitoring was 22.662.4 hours;
the mean6SD number of measurements was 45.264.9 (n51542).
Artifactual readings during ABPM were defined according to previ-
ously described criteria28 and were omitted from the analysis. The
average 24-hour values for ABP were calculated for each subject.
Residence in Ohasama as of August 30, 1997, was confirmed by
the residents’ registration cards. These cards in Japan are accurate
and reliable because they are the basis for pensions and social
security benefits. Twelve subjects (0.8%) moved away and were lost
to follow-up. There were 117 deaths (7.6%) identified by the
residents’ registration cards. Death certificates were obtained from
the Ohasama Health Department, and the cause of death was
classified according to the recommendations of the World Health
Organization’s International Classification of Diseases, 10th Revi-
sion (ICD-10), by which deaths are attributed to the underlying cause
initiating the sequence of events leading to mortality. The mean6SD
duration of follow-up was 6.262.1 years (range, 0.01 to 9.3 years).
The leading cause of death was cancer (35 deaths, 30%), followed by
cerebrovascular disease (25 deaths, 21%) and heart disease (15
deaths, 13%).
The association between the baseline ABP levels and mortality
was examined using the Cox proportional hazards regression model29
adjusted for age, gender, smoking status, use of antihypertensive
medication at baseline, and history of cardiovascular disease, diabe-
tes, and hypercholesterolemia, using the SAS PHREG procedure.30
The dependent variable was the number of days from the date of
ABPM to the date of death or withdrawal from the study. Survivors
were withdrawn on August 30, 1997.
The association between the ABP level and mortality was esti-
mated parametrically. In this analysis, the ABP level was a contin-
uous variable in the regression model. Parametric analysis using the
Cox model usually assumes a linear relation in a logarithmic scale
between dependent and independent variables.29 In the present study,
we examined the association using the following formula:
ln(RH)5b1(BP)1a, where b was the regression coefficient of each
variable and a was the intercept calculated according to the con-
founding factors used to adjust the association between ABP level
and mortality. However, our previous nonparametric analysis indi-
cated that there was a possibility of a nonlinear association between
ABP and mortality23,31 and that this association would show a better
fit to an equation of the second degree rather than of the first degree.
Thus, we also analyzed the data using the following formula:
ln(RH)5b1(BP)21b2(BP)1a.
We performed parametric analysis of both the first-degree and
second-degree models. The appropriateness of the addition of BP2 as
an independent variable was examined by comparing the log
likelihood ratios of the models.29 The difference between the log
likelihood ratios is testing the significance in contribution of BP2 to
the model. This value follows a x2 distribution with 1 df.
The information on smoking status, use of antihypertensive
medication at baseline, and history of cardiovascular disease, diabe-
tes, and hypercholesterolemia was obtained both from questionnaires
sent to each household at the time of ABP measurements and from
medical records at Ohasama Hospital, the only hospital in the town,
where .90% of the subjects go for regular checkups. Of the 1542
study subjects, 334 (22%) were classified as current or ever-smokers,
and 473 (31%) were receiving antihypertensive medication. History
of cardiovascular disease, diabetes, or hypercholesterolemia was
identified in 69 subjects (5%), 265 subjects (17%), and 248 subjects
(16%), respectively.
The estimated RH and 95% CI of variables were derived from the
coefficient and its standard error, as determined by the Cox propor-
tional hazards model. Data are mean6SD. A value of P,0.05 was
accepted as indicating statistical significance.
Results
The mean 24-hour SBP was 123.3613.0 mm Hg (range, 91
to 181) and the mean 24-hour DBP was 72.067.7 mm Hg
(range, 49 to 105).
There was a nonlinear association between crude mortality
rate and 24-hour blood pressure values (Figure 1).
The 24-hour SBP was not significantly related to overall
mortality based on the results of analysis using the first-
degree equation (Table 1). When data were fitted to the
second-degree equation, both SBP and SBP2 were signifi-
cantly related to overall mortality. The difference in the log
likelihood ratio between the first-degree and the second-
degree models was 14.6 (P,0.001), indicating that the
Figure 1. Relation between crude mortality rate and 24-hour
values for SBP (a) and DBP (b).
Selected Abbreviations and Acronyms
ABP(M) 5 ambulatory blood pressure (monitoring)
CI 5 confidence interval
DBP 5 diastolic blood pressure
RH 5 relative hazard
SBP 5 systolic blood pressure
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inclusion of SBP2 significantly improved the fit. For the
relationship between 24-hour DBP and overall mortality, the
addition of DBP2 also significantly improved the fit: the
difference in the log likelihood ratio between the first-degree
and the second-degree models was 6.6 (P,0.02) (Table 2).
On the basis of these findings, we illustrated the associa-
tion between ABP values and the RHs as the second-degree
equation curves (Figure 2). RH was determined relative to the
RH of the preceding 1 mm Hg of blood pressure and was
calculated according to the following formula: ln(RH)5(b of
BP)3[BP2(BP21)]1(b of BP2)3[BP22(BP21)2]. The
95% CI was calculated according to the following formula:
ln(95% CI)5ln(RH)61.963SE of ln(RH). The standard
error of ln(RH) was calculated from the standard errors of BP
and BP2 and from the covariance between BP and BP2. The
standard errors of BP and BP2 and the covariance between BP
and BP2 was determined by the Cox proportional hazards
model adjusted for age, gender, smoking status, use of
antihypertensive medication at baseline, and history of car-
diovascular disease, diabetes, and hypercholesterolemia. The
standard errors of BP and BP2 are shown in Table 1 for
24-hour SBP and in Table 2 for 24-hour DBP. The covariance
between 24-hour SBP and 24-hour SBP2 was 21.8531025,
and the covariance between 24-hour DBP and 24-hour DBP2
was 21.0931024.
An RH ,1.0 indicates that the mortality risk decreases as
blood pressure increases; an RH .1.0 indicates that the risk
increases as blood pressure increases. Thus, the lowest
mortality risk was associated with an RH of 1.0, which
corresponded to SBP of 128 mm Hg and DBP of 74 mm Hg.
We defined the ranges for optimal blood pressures as the
values between the upper and lower 95% CIs for an RH of
1.0, corresponding to 120 to 133 mm Hg for SBP and 65 to
78 mm Hg for DBP (Figure 2). Hypertension was defined as
24-hour blood pressure .134 mm Hg for SBP and
.79 mm Hg for DBP; low blood pressure was defined as
SBP ,119 mm Hg and DBP ,64 mm Hg. SBP of
134 mm Hg and DBP of 79 mm Hg corresponded to the 82nd
and 80th percentiles of the study population, respectively.
When we examined the relation between these blood
pressure categories and mortality with the Cox proportional
hazards model for 24-hour SBP and DBP using the normo-
tensive group as the reference category, we found that the
mortality risk increased significantly for 24-hour SBP in the
hypertensive group (RH51.95, P50.0056) and the low blood
pressure group (RH51.80, P50.0139) (Table 3). The RH for
mortality increased significantly for 24-hour DBP in the
hypertensive group (RH51.59, P50.0454) but did not sig-
nificantly increase for 24-hour DBP in the low blood pressure
group (RH51.48, P50.1264).
The excess mortality risk in the hypertensive group was
largely attributable to cardiovascular mortality (SBP:
RH51.96, P50.0441; DBP: RH52.22, P50.0235; com-
pared with the low blood pressure and normotensive groups)
(Table 4), and the excess mortality risk in subjects with low
blood pressure was largely attributable to noncardiovascular
mortality (SBP: RH51.55, P50.0636; DBP: RH51.50,
P50.1728; compared with the normotensive and hyperten-
sive groups).
TABLE 1. Relation Between Overall Mortality and 24-Hour SBP
Determined by Cox Proportional Hazards Model Adjusted for
Age, Gender, Use of Antihypertensive Medication, Smoking
Status, and History of Cardiovascular Disease, Diabetes,
and Hypercholesterolemia
Variable Coefficient SE P
First-degree model
24-Hour SBP 0.00742 0.00735 0.313
22 log likelihood5175.784 (P,0.001)
Second-degree model
24-Hour SBP 20.30165 0.07037 ,0.001
24-Hour SBP2 0.00118 0.00026 ,0.001
22 log likelihood5190.384 (P,0.001)
TABLE 2. Relation Between Overall Mortality and 24-Hour DBP
Determined by Cox Proportional Hazards Model Adjusted for
Age, Gender, Use of Antihypertensive Medication, Smoking
Status, and History of Cardiovascular Disease, Diabetes,
and Hypercholesterolemia
Variable Coefficient SE P
First-degree model
24-Hour DBP 0.00405 0.01289 0.754
22 log likelihood5174.872 (P,0.001)
Second-degree model
24-Hour DBP 20.36265 0.12841 0.005
24-Hour DBP2 0.00246 0.00085 0.004
22 log likelihood5181.503 (P,0.001)
Figure 2. RH (solid line) and 95% CIs (broken lines) of 24-hour
SBP (a) and DBP (b) values for overall mortality, approximated
as the curves fitted to the second-degree equation determined
by the Cox proportional hazards model adjusted for age, gen-
der, smoking status, use of antihypertensive medication at
baseline, and history of cardiovascular disease, diabetes, and
hypercholesterolemia.
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Discussion
The present study was based on a longitudinal observation of
a representative sample of the general population in a rural
Japanese community. The association between ABP values
and overall mortality fit better to a second-degree equation
than to a first-degree equation. On the basis of the results of
this analysis, we identified the following reference values as
the optimal blood pressure ranges that predict the best
prognosis: 120 to 133 mm Hg for SBP and 65 to 78 mm Hg
for DBP. ABP values .134/79 mm Hg and ,119/64 mm Hg
were related to an increased risk for cardiovascular and
noncardiovascular mortality, respectively.
Several studies have examined the association between
ABP levels and morbidity and mortality among hypertensive
subjects.10–12 Perloff et al10 reported that patients whose
average daytime ABP exceeded their casual blood pressure
had an increased risk of serious cardiovascular complications.
Verdecchia et al12 reported that the cardiovascular morbidity
rate was significantly higher in subjects with ambulatory
hypertension than in the subjects with white coat hyperten-
sion. These studies indicated that ABP was a stronger
predictor of morbidity than casual blood pressure, but refer-
ence values for ABP could not be identified because these
study populations included only hypertensive subjects and
did not include normotensive subjects. In the present study,
we proposed reference values for ABP based on a longitudi-
nal observation of a general population that included both
normotensive and hypertensive subjects.
Reference values for ABP have been proposed in a number
of studies based on cross-sectional analysis of subjects with
normal casual blood pressures.18–22 In these studies, the upper
limit of ABP was determined according to the statistical
distribution of ABPs such as the mean1SD, the mean12SD,
and the 95th percentile. Using data from an international
database, Staessen et al19 reported that the 95th percentile
of 24-hour ABP in clinically normotensive subjects was
134/82 mm Hg. The mean12SD of 24-hour ABP in normo-
tensive subjects was 134/84 mm Hg in the Allied Irish
Bank study,20 130/81 mm Hg in the PAMELA study,21 and
131/81 mm Hg in a Belgian population study.22 In our
previous cross-sectional analysis of the first cohort of
Ohasama,18 the 95th percentile of 24-hour ABP in clinically
normotensive subjects was 134/79 mm Hg.
Several national organizations have also recommended an
upper limit of 24-hour ABP: the American Society of Hyper-
tension recommends 130 to 135/80 to 85 mm Hg14 and the
German Hypertension League recommends 130/80 mm Hg.15
However, there is no evidence that these recommended and
statistically derived values predict mortality or morbidity.
Reference values are important factors in deciding on the
diagnosis and treatment of hypertension and thus should be
related to prognosis. In the present study, we identified the
reference values for ABP in relation to prognosis and con-
firmed that the proposed reference values predicted the
mortality risk in the general population well.
The reference values for hypertension in the present study
(134/79 mm Hg) are consistent with the values derived from
our previous cross-sectional study18 and with the mean1SD
of 24-hour ABP for the present subjects (136/80 mm Hg).
The reference values in the present study are also similar to
those proposed in cross-sectional studies and recommended
by national organizations. It is of interest that our mortality-
based values coincided remarkably with these recommended
and statistically derived values, although these values were
calculated independently.
Because the present reference values were derived from a
population-based study in a rural Japanese community, ap-
plicability of the findings to the whole Japanese population
should be discussed. The average casual blood pressure
values in this population (131.1/74.3 mm Hg for males and
129.1/72.7 mm Hg for females)18 were consistent with
the national average (132.4/79.8 mm Hg for males and
127.2/76.0 mm Hg for females),32 which was derived from
the national survey of all Japan.32 Although the national
average of ABP values is not available, the consistency of
casual blood pressure values between the present population
and the whole Japanese population suggests that the present
reference values could be extrapolated to the majority of
Japanese persons.
Although ABPM is the focus of clinical interest, its
usefulness has yet to be established, in part because the
prognostic value of ABPM has not been fully evaluated
and because there are no established reference values. The
reference value should accurately predict the risks of
mortality and morbidity. In the present study, we identified
the following reference values as the optimal blood pres-
sure ranges that predict the best prognosis: 120 to
133 mm Hg for SBP and 65 to 78 mm Hg for DBP. A
24-hour ABP value .134/79 mm Hg was the best predic-
TABLE 3. RH and 95% CI of Reference Values for 24-Hour
ABP for Overall Mortality Adjusted for Age, Gender, Use of
Antihypertensive Medication, Smoking Status, and History of
Cardiovascular Disease, Diabetes, and Hypercholesterolemia
Variable RH (95% CI)
SBP, mm Hg
%119 (low blood pressure) 1.80 (1.13–2.87)
120–133 (normotension) 1.0
^134 (hypertension) 1.95 (1.22–3.12)
DBP, mm Hg
%64 (low blood pressure) 1.48 (0.90–2.43)
65–78 (normotension) 1.0
^79 (hypertension) 1.59 (1.01–2.51)
TABLE 4. RH and 95% CI of Reference Values for 24-Hour
ABP for Cardiovascular Mortality Adjusted for Age, Gender, Use
of Antihypertensive Medication, Smoking Status, and History of
Cardiovascular Disease, Diabetes, and Hypercholesterolemia
Variable RH (95% CI)
SBP, mm Hg
%133 (low blood pressure and normotension) 1.00
^134 (hypertension) 1.96 (1.02–3.78)
DBP, mm Hg
%78 (low blood pressure and normotension) 1.00
^79 (hypertension) 2.22 (1.11–4.43)
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tor of cardiovascular mortality. Additional population-
based prospective studies in other countries and studies
using different prognostic parameters are needed to con-
firm the reference values proposed in the present study.
Several population-based studies in western countries21,22
may provide useful prognostic information in future.
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